Webinar: Open Call – Prediction of clinical trial outcome in oncology -
CTO,
AION Labs
CEO,
AION Labs
Managing Director & Founder,
Biomed X Institue
When: July 18, 2022 6:00 pm
Where: -Online
About
This webinar addresses FAQs about AION Labs’ 4th Call for Application, titled Prediction of Clinical Trial Outcome in Biomarker-Stratified Cancer Patient Populations, open until August 28, 2022
AION Labs, the Israel-based venture studio by AstraZeneca, Merck, Pfizer, Teva, Israel Biotech Fund, Amiti Ventures and Amazon Web Services (AWS) – powered by BioMed X – is supporting the establishment of a new, fully funded startup company in the field of clinical trial outcome prediction in biomarker-stratified cancer patient populations.
Each AION Labs startup team is sponsored by several industry-leading partners and supported by the Israel Innovation Authority. The sponsors of this call for application are AstraZeneca, Merck, Pfizer, and Teva, with close support from AWS.